P2X7 Antagonist therapy (Suven Life Sciences)

N/A

Report date: 2024/10/11 11:20:28
NME

Base Information

Drug NameP2X7 Antagonist therapy (Suven Life Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsPainInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A